Español
PDFs by language
Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
A risk factor is anything that raises your chance of getting a disease such as cancer. Different cancers have different risk factors. Some risk factors, like smoking or sun exposure, can be changed. Others, like a person’s age or family history, can’t be changed.
Although certain factors can increase the risk for , they don't always cause the disease. Many who have risk factors never develop endometrial cancer.
Some with endometrial cancer don't have any known risk factors. Even if someone with endometrial cancer has one or more risk factors, theres no way to know which, if any, of them caused the cancer.
Estrogen-replacement therapy is given to improve symptoms of menopause. No progestin (another hormone) is given. This is called unopposed estrogen therapy. This can be given in the form of a pill, patch, or vaginal ring. It is a risk factor when the person taking it still has a uterus. For more information about the cancer risks linked to hormone treatment after menopause, see Menopausal Hormone Therapy and Cancer Risk.
Tamoxifen is a drug that is used to help prevent and treat breast cancer. Tamoxifen acts as an anti-estrogen in breast tissue, but it acts like an estrogen in the uterus. The risk of developing endometrial cancer from tamoxifen is very low (less than 1% per year). Because the risk is so low, the benefits of tamoxifen almost always outweigh the rare risk of endometrial cancer. If you have concerns about your uterine cancer risk and your breast cancer treatment plan includes tamoxifen, talk to your health care team.
Starting menstruation at a young age and going through menopause at a late age increases the exposure of the endometrium to estrogen and therefore increases the risk of endometrial cancer.
The risk of endometrial cancer is higher if you have never been pregnant compared to having at least one pregnancy.
Having a medical condition such as polycystic ovary syndrome (PCOS) and estrogen-secreting ovarian tumors increases the risk of uterine cancer.
The ovaries produce the most estrogen before menopause. But fat tissue can change a hormone called androgen into estrogen. Having more fat tissue can increase estrogen levels, especially after menopause, which increases the risk of endometrial cancer.
Metabolic syndrome is a combination of medical conditions that typically includes obesity, diabetes, and hypertension. These conditions are linked to an increased risk of endometrial cancer.
A high-fat diet can increase the risk of many cancers, including endometrial cancer. Because fatty foods are also high-calorie foods, a high-fat diet can lead to obesity, which is a well-known endometrial cancer risk factor. To learn more, read the American Cancer Society Guidelines on Nutrition and Physical Activity for Cancer Prevention.
Endometrial hyperplasia is an increased growth of the endometrium. If the hyperplasia is called atypical, it has a higher chance of becoming a cancer.
The risk of endometrial cancer increases with age and most commonly occurs after menopause.
Lynch syndrome or hereditary non-polyposis colon cancer (HNPCC) and Cowden syndrome are genetic conditions that increase the risk of endometrial cancer. More information about inherited cancer syndromes can be found in Family Cancer Syndromes.
Some families have a higher rate of only endometrial cancer. These families may have a different genetic disorder that hasn't been found yet.
Black people have a higher chance of being diagnosed with advanced endometrial cancer. Black people and Hispanic people also have a higher risk of developing more aggressive tumors.
Some studies have found that using chemical hair straighteners (relaxers) often and for many years might increase the risk of endometrial cancer. However, scientists aren’t sure which chemical in the straighteners might be causing this risk. Further studies have found that the increased risk for endometrial cancer was particularly high in Black women who are post-menopausal.
Previous radiation therapy for another cancer in the pelvic area, which is the lower part of the abdomen between the hip bones, increases the risk of endometrial cancer.
Oral contraceptives pills (OCP) including both estrogen-progestin contraceptives as well as progestin-only contraceptives. The risk is lowest when they are taken long-term, and this protection lasts for at least 10 years after the pills are stopped.
Both progesterone-containing IUDs and copper IUDs decrease the risk of endometrial cancer.
If you use hormone therapy after menopause, use of a medication that contains both estrogen and progesterone will help reduce risk.
During pregnancy, the level of progesterone is high, which protects against endometrial cancer. Multiple pregnancies decrease the risk even more. Breastfeeding also is associated with a decrease in a mother's uterine cancer risk.
An increase in physical activity can help maintain a healthy weight and lower your risk of endometrial cancer.
Developed by the American Cancer Society medical and editorial content team with medical review and contribution by the American Society of Clinical Oncology (ASCO).
Bertrand KA, Delp L, Coogan PF, Cozier YC, Lenzy YM, Rosenberg L, Palmer JR. Hair relaxer use and risk of uterine cancer in the Black Women's Health Study. Environ Res. 2023 Dec 15;239(Pt 1):117228. doi: 10.1016/j.envres.2023.117228. Epub 2023 Oct 10. PMID: 37821068; PMCID: PMC10842360.
Esposito K, Chiodini P, Capuano A, et al. Metabolic syndrome and endometrial cancer: a meta-analysis. Endocrine. 2014;45(1):28-36.
Front Oncol. 2019; 9: 744. Published online 2019 Aug 8. doi: 10.3389/fonc.2019.00744.PMCID: PMC6694738PMID: 3144047
MacKintosh ML, Crosbie EJ. Prevention Strategies in Endometrial Carcinoma. Curr Oncol Rep. 2018;20(12):101.
National Cancer Institute. Endometrial Cancer Prevention (PDQ®)–Health Professional Version, March 15, 2024. Accessed at www.cancer.gov/types/uterine/hp/endometrial-prevention-pdq#section/all on July 17, 2024.
National Cancer Institute. Endometrial Cancer Treatment (PDQ®)–Patient Version. Nov 13, 2024. Accessed at www.cancer.gov/types/uterine/patient/endometrial-treatment-pdq on July 17, 2024.
Ring KL, Mills AM, Modesitt SC. Endometrial Hyperplasia. Obstet Gynecol. 2022 Dec 1;140(6):1061-1075. doi: 10.1097/AOG.0000000000004989. Epub 2022 Nov 2. PMID: 36357974
Last Revised: February 28, 2025
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.
Sign up to stay up-to-date with news, valuable information, and ways to get involved with the American Cancer Society.